Drug Trial Radar · NCT02005302
Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition
Last checked: Nov 19, 2026Latest source record: Dec 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
600
Planned (sponsor's estimate)
Start
Jan 2013
Primary completion
Dec 2015
Study completion Dec 2016
Sponsor
- Lead sponsor
- Wenhu LiuAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beijing Municipal Science & Technology Commission
- First posted
- Dec 9, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi-center, prospective, randomized, controlled study to verify the clinical effectiveness of K / DOQI guidelines. The efficiency and safety of Vitamin D2 and low protein diet treatment for prevention and treatment of CKD-MBD and malnutrition in CKD3-5 (ND) patients.
Conditions
- Vitamin D Deficiency
- Malnutrition
Interventions
1,25(OH)2 Vitamin D3Drug
Oral 1,25(OH)2 Vitamin D3 by 0.25 microgram once daily at start and regulate the dose according to the changes of blood levels of 25(OH)Vit D, calcium, phosphorus, and intact parathyroid hormone.
Vitamin D2Drug
Oral Vit D2 1.25mg(50,000 unit) once weekly as a start and maintain 1.25mg(50,000 unit) once monthly according to the blood 25(OH)vitamin D level.
low protein dietDietary supplement
Using nutritious software to make meals recipes and give dietary guidance for patients to reach the DPI goal of 0.6g-0.8g/kg/d.
normal protein dietDietary supplement
Using nutritious software to make meals recipes and give dietary guidance for patients to reach the DPI goal of more than 0.8g/kg/d.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The changes on the blood levels of calcium, phosphorus, and intact parathyroid (iPTH) hormone during 36 monthsTime frame: 36 months
- The changes on the clinical indicators of nutritional statusTime frame: 36 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Beijing XuanWu Hospital
Beijing, Beijing Municipality, China
People's Liberation Army Air Force General Hospital
Beijing, Beijing Municipality, China
People's Liberation Army General Hospital
Beijing, Beijing Municipality, China
Sino-Japanese Friendship Hospital
Beijing, Beijing Municipality, China
Beijing Friedship Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.